LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,472 | -27.8% | 6,600 | -13.2% | 0.00% | 0.0% |
| Q2 2023 | $547,960 | -11.3% | 7,600 | -9.5% | 0.00% | -50.0% |
| Q1 2023 | $617,904 | -19.6% | 8,400 | -27.0% | 0.00% | 0.0% |
| Q4 2022 | $768,200 | +242.9% | 11,500 | +342.3% | 0.00% | +100.0% |
| Q3 2022 | $224,000 | -7.1% | 2,600 | -3.7% | 0.00% | 0.0% |
| Q2 2022 | $241,000 | -2.4% | 2,700 | +22.7% | 0.00% | 0.0% |
| Q1 2022 | $247,000 | -15.7% | 2,200 | +15.8% | 0.00% | 0.0% |
| Q4 2021 | $293,000 | -91.6% | 1,900 | -91.7% | 0.00% | -90.0% |
| Q1 2021 | $3,487,000 | -39.7% | 22,872 | -60.7% | 0.01% | -33.3% |
| Q4 2020 | $5,785,000 | -64.7% | 58,172 | -66.2% | 0.02% | -68.1% |
| Q3 2020 | $16,392,000 | -24.9% | 171,972 | -11.9% | 0.05% | -26.6% |
| Q2 2020 | $21,830,000 | +56.5% | 195,172 | +1.7% | 0.06% | +20.8% |
| Q1 2020 | $13,953,000 | -46.7% | 191,872 | -23.6% | 0.05% | -13.1% |
| Q4 2019 | $26,184,000 | -0.6% | 251,072 | -5.2% | 0.06% | -6.2% |
| Q3 2019 | $26,355,000 | -27.6% | 264,772 | -17.0% | 0.06% | -28.6% |
| Q2 2019 | $36,399,000 | -11.8% | 318,872 | -2.9% | 0.09% | -12.5% |
| Q1 2019 | $41,292,000 | +75.2% | 328,472 | +89.1% | 0.10% | +62.5% |
| Q4 2018 | $23,567,000 | -43.9% | 173,672 | +13.5% | 0.06% | -37.3% |
| Q3 2018 | $41,994,000 | +8.1% | 152,988 | -18.4% | 0.10% | -2.9% |
| Q2 2018 | $38,863,000 | +54.8% | 187,588 | +23.4% | 0.10% | +54.4% |
| Q1 2018 | $25,102,000 | +1239.5% | 151,988 | +1010.4% | 0.07% | +1260.0% |
| Q4 2017 | $1,874,000 | +193.7% | 13,688 | +192.0% | 0.01% | +150.0% |
| Q3 2017 | $638,000 | +211.2% | 4,688 | +177.7% | 0.00% | +100.0% |
| Q2 2017 | $205,000 | -13.9% | 1,688 | -23.0% | 0.00% | 0.0% |
| Q4 2015 | $238,000 | -4.0% | 2,192 | -24.2% | 0.00% | -50.0% |
| Q3 2015 | $248,000 | -12.1% | 2,892 | +3.6% | 0.00% | 0.0% |
| Q2 2015 | $282,000 | -87.2% | 2,792 | -90.2% | 0.00% | -88.2% |
| Q1 2015 | $2,197,000 | +51.3% | 28,492 | +4.4% | 0.02% | +41.7% |
| Q4 2014 | $1,452,000 | +42.5% | 27,292 | +25.8% | 0.01% | +50.0% |
| Q3 2014 | $1,019,000 | -2.0% | 21,692 | +30.0% | 0.01% | 0.0% |
| Q2 2014 | $1,040,000 | +175.9% | 16,692 | +198.5% | 0.01% | +166.7% |
| Q1 2014 | $377,000 | +7.1% | 5,592 | -40.5% | 0.00% | -40.0% |
| Q2 2013 | $352,000 | – | 9,392 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |